Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
142M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
74.2K
-
Shares change
-
+34.2K
-
Total reported value, excl. options
-
$249K
-
Value change
-
+$115K
-
Number of buys
-
2
-
Price
-
$3.35
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q4 2023
3 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q4 2023.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74.2K shares
of 142M outstanding shares and own 0.05% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (7.02M shares), VR Adviser, LLC (6.25M shares), Knoll Capital Management, LLC (5.47M shares), Propel Bio Management, LLC (5.37M shares), Vestal Point Capital, LP (4.16M shares), PERCEPTIVE ADVISORS LLC (4.08M shares), VANGUARD GROUP INC (3.23M shares), Alyeska Investment Group, L.P. (2.6M shares), FMR LLC (2.43M shares), and Simplify Asset Management Inc. (2.42M shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.